Newsbenzinga
AstraZeneca, Amgen Report Phase III Results For TEZSPIRE In Eosinophilic Esophagitis; TEZSPIRE Meets Key Endpoints In Phase III CROSSING Trial
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…